Reduced lung diffusion capacity in type 2 diabetes is independent of heart failure

Oana L. Klein*, Madeline Jones, Jungwha Lee, Harold R. Collard, Lewis J. Smith

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

In a case-control analysis comparing 303 patients with diabetes and 303 without (matched on age, race, sex and height), diabetics had reduced lung diffusion (DLCO) independent of smoking, obesity, clinical heart failure, asymptomatic left ventricular systolic and diastolic dysfunction: DLCO (mean ± SE: 15.5 ± 0.9 vs. 16.4 ±0.9, p=. 0.01).

Original languageEnglish (US)
Pages (from-to)e73-e75
JournalDiabetes Research and Clinical Practice
Volume96
Issue number3
DOIs
StatePublished - Jun 2012

Keywords

  • Diabetes
  • Diffusing capacity for carbon monoxide
  • Echocardiogram
  • Heart failure
  • Microangiopathy
  • Pulmonary function tests

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'Reduced lung diffusion capacity in type 2 diabetes is independent of heart failure'. Together they form a unique fingerprint.

Cite this